Literature DB >> 11159229

The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery.

Y Sun1, P E Greilich, S I Wilson, M R Jackson, C W Whitten.   

Abstract

The method of anticoagulation in patients undergoing major vascular surgery with a history of heparin-induced thrombocytopenia (HIT) is controversial. We present two cases in which a bolus only technique using recombinant hirudin (Lepirudin or Refludan) was used successfully in patients with HIT scheduled for vascular surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159229     DOI: 10.1097/00000539-200102000-00012

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Elevated heparin-induced antibodies are more common in diabetic patients with vascular disease.

Authors:  Joseph J Naoum; Nibal R Chamoun; Mitul S Patel; Tiffany K Street; Mazen Haydar; Jean Bismuth; Hosam F El-Sayed; Mark G Davies; Alan B Lumsden; Eric K Peden
Journal:  Thrombosis       Date:  2014-02-06

2.  Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases.

Authors:  Giulio Illuminati; Francesco G Calio'; Giulia Pizzardi; Chiara Amatucci; Federica Masci; Piergaspare Palumbo
Journal:  Int J Surg Case Rep       Date:  2016-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.